Picturing asthma in Turkey: results from the Turkish adult asthma registry
No Thumbnail Available
Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Introduction: National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry for patients with asthma aiming to take a snapshot of our patients, thereby assigning the unmet needs and niche areas of intervention. Methods: Case entries were performed between March 2018 and March 2022. A web-based application was used to record data. Study outcomes were demographic features, disease characteristics, asthma control levels, and phenotypes. Results: The registry included 2053 patients from 36 study centers in Turkey. Female subjects dominated the group (n = 1535, 74.8%). The majority of the patients had allergic (n = 1158, 65.3%) and eosinophilic (n = 1174, 57.2%) asthma. Six hundred nineteen (32.2%) of the patients had obese asthma. Severe asthma existed in 670 (32.6%) patients. Majority of cases were on step 3–5 treatment (n: 1525; 88.1%). Uncontrolled asthma was associated with low educational level, severe asthma attacks in the last year, low FEV1, existence of chronic rhinosinusitis and living in particular regions. Conclusion: The picture of this registry showed a dominancy of middle-aged obese women with moderate-to-severe asthma. We also determined particular strategic targets such as low educational level, severe asthma attacks, low FEV1, and chronic rhinosinusitis to decrease uncontrolled asthma in our country. Moreover, some regional strategies may also be needed as uncontrolled asthma is higher in certain regions. We believe that these data will guide authorities to reestablish national asthma programs to improve asthma service delivery. © 2023 Taylor & Francis Group, LLC.
Description
Keywords
Adult , Asthma , Female , Humans , Middle Aged , Obesity , Registries , Turkey , acetylsalicylic acid , beta adrenergic receptor stimulating agent , budesonide plus formoterol , corticosteroid , fluticasone furoate plus vilanterol , fluticasone propionate plus salmeterol , formoterol , leukotriene receptor blocking agent , long acting drug , mepolizumab , muscarinic agent , nonsteroid antiinflammatory agent , omalizumab , salmeterol , adult , aged , allergic asthma , allergic rhinitis , Article , asthma , Asthma Control Test , atopy , Black Sea , chronic rhinosinusitis , cockroach , comorbidity , corticosteroid therapy , current smoker , desensitization , disease duration , disease registry , disease severity , drug hypersensitivity , educational status , emergency care , eosinophilia , eosinophilic asthma , female , forced expiratory volume , forced vital capacity , hospitalization , human , lung function test , major clinical study , male , maximal mid expiratory flow , mold allergy , nose polyp , obesity , peak expiratory flow , phenotype , pollen allergy , severe asthma , spirometry , Turkey (republic) , asthma , complication , epidemiology , middle aged , register , turkey (bird)